RNF181 inhibitors belong to a distinctive chemical class known for their specific interactions with the RNF181 protein, a member of the RING-type E3 ubiquitin ligase family. This class of inhibitors is characterized by their ability to modulate the enzymatic activity of RNF181, which plays a crucial role in the ubiquitin-proteasome system. The RNF181 protein functions as an E3 ubiquitin ligase, facilitating the transfer of ubiquitin molecules to target proteins and thereby marking them for degradation by the proteasome. By selectively inhibiting the catalytic function of RNF181, compounds in this chemical class exert a regulatory influence on the ubiquitin-proteasome pathway, influencing the degradation dynamics of various cellular proteins.
Structurally, RNF181 inhibitors typically feature distinctive molecular motifs that enable them to bind selectively to the active site of the RNF181 protein, disrupting its ubiquitination activity. The interaction between the inhibitor and the target protein involves intricate molecular recognition events, often exploiting specific binding pockets on RNF181. This class of compounds has garnered significant attention in the field of chemical biology and drug discovery due to the pivotal role of the ubiquitin-proteasome system in maintaining cellular homeostasis and regulating diverse cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can prevent the degradation of ubiquitinated proteins, potentially increasing the abundance of proteins that can inhibit RNF181 activity by competitive interaction. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
An autophagy inhibitor that may increase cellular protein levels, possibly leading to the stabilization of proteins that negatively regulate RNF181. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins, which may include negative regulators of RNF181. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
A thiol protease inhibitor that may interfere with protein degradation pathways, potentially affecting RNF181 regulatory proteins. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
This compound inhibits cysteine proteases, potentially altering protein turnover and indirectly impacting RNF181 function. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A specific inhibitor of the proteasome that may lead to the accumulation of proteins that regulate RNF181 indirectly. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
An inhibitor of NEDD8-activating enzyme, potentially affecting ubiquitination processes and indirectly impacting RNF181 activity. | ||||||
PD 150606 | 179528-45-1 | sc-222133 sc-222133A | 5 mg 25 mg | $118.00 $403.00 | 18 | |
An allosteric inhibitor of calpain that, by inhibiting this protease, may influence the turnover of proteins involved in the regulation of RNF181. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
An inhibitor of thioredoxin reductase that may disrupt cellular redox homeostasis and indirectly affect RNF181 function. | ||||||